Model-based prediction of myelosuppression and recovery based on frequent neutrophil monitoring.

Daily monitoring of the ANC, together with model-based predictions, could improve anticancer drug treatment by identifying patients at risk for severe neutropenia and predicting when the next cycle could be initiated.